Alexza Pharmaceuticals Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 104

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $55M

Alexza Pharmaceuticals General Information

Description

Developer of novel products designed to be used for the acute treatment of central nervous system conditions. The company's novel products are based on the Staccato system, a hand-held inhaler designed to deliver a drug aerosol to the deep lung, providing rapid systemic delivery and therapeutic onset in a non-invasive manner, enabling patients suffering from agitation due to schizophrenia or bipolar I disorder get faster relief.

Contact Information

Website
www.alexza.com
Formerly Known As
Alexza Molecular Delivery Corporation, FaxMed
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Drug Delivery
Other Industries
Pharmaceuticals
Drug Discovery
Parent Company
Ferrer Internacional
Primary Office
  • 2091 Stierlin Court
  • Mountain View, CA 94043
  • United States
+1 (650) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Alexza Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
16. Merger/Acquisition 21-Jun-2016 $55M 00000 000.00 Completed Clinical Trials - Phase 1
15. PIPE 24-Feb-2016 000 00000 Completed Clinical Trials - Phase 1
14. PIPE 28-Oct-2014 0000 00000 Completed Clinical Trials - Phase 1
13. PIPE 23-Jul-2012 0000 00000 Completed Clinical Trials - Phase 1
12. 2PO 17-Feb-2012 0000 00000 Completed Clinical Trials - Phase 1
11. PIPE 26-May-2010 0000 00000 Completed Clinical Trials - Phase 1
10. Debt - General 05-May-2010 0000 00000 Completed Clinical Trials - Phase 1
9. PIPE 06-Oct-2009 000.00 00000 Completed Clinical Trials - Phase 1
8. PIPE 31-Mar-2008 $60M $229M Completed Clinical Trials - Phase 1
7. 2PO 05-Jul-2007 $18.7M $169M Completed Clinical Trials - Phase 1
To view Alexza Pharmaceuticals’s complete valuation and funding history, request access »

Alexza Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of novel products designed to be used for the acute treatment of central nervous system conditions. The compan
Drug Delivery
Mountain View, CA
104 As of 2023
00000
00.00 0000-00-00
000000&0 00000

000000

ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex e
0000 000000000
Radnor, PA
000 As of 0000
00000
00000000 00000

000000

a commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit e
000000000000000
Austin, TX
00 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Alexza Pharmaceuticals Competitors (46)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Marinus Pharmaceuticals Formerly VC-backed Radnor, PA 000 00000 00000000 00000
0000000 00000000 Formerly VC-backed Austin, TX 00 00000 000000000 00000
000000 000000 Corporation Stamford, CT 000 0000000000.
00000000 000000000 Corporation Coral Gables, FL 00 000.00 00000000 000.00
00000000 000000000 Corporate Backed or Acquired San Diego, CA 000 00000 000000&0
You’re viewing 5 of 46 competitors. Get the full list »

Alexza Pharmaceuticals Patents

  • 598

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 27

    Granted

  • 1

    Pending

  • 000

    Expiring in next 12 mo

Alexza Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3090277-A1 Electrical condensation aerosol device Pending 02-Feb-2018 000000000
EP-3746138-A1 Electrical condensation aerosol device Pending 02-Feb-2018 000000000
EP-3746138-A4 Electrical condensation aerosol device Pending 02-Feb-2018 000000000 0
JP-2021511893-A Electric condensed aerosol device Pending 02-Feb-2018 000000000 0
US-20210046259-A1 Electrical condensation aerosol device Pending 02-Feb-2018 A61P11/00
To view Alexza Pharmaceuticals’s complete patent history, request access »

Alexza Pharmaceuticals Executive Team (18)

Name Title Board Seat Contact Info
Tatjana Naranda Ph.D President & Chief Operating Officer
Edwin Kamemoto Ph.D Executive Vice President, Research & Development, Regulatory and Quality
Michael Simms Senior Vice President, Manufacturing and Operations
Stacy Palermini Senior Vice President, Sustainability
Chris Kurtz Vice President, Global Supply Chain
You’re viewing 5 of 18 executive team members. Get the full list »

Alexza Pharmaceuticals Board Members (10)

Name Representing Role Since
Isaac Stein JD Self Lead Director 000 0000
You’re viewing 1 of 10 board members. Get the full list »

Alexza Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Alexza Pharmaceuticals Former Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
5AM Ventures Venture Capital Minority 000 0000 000000 0
Abingworth Venture Capital Minority 000 0000 000000 0
Alloy Ventures Venture Capital Minority 000 0000 000000 0
Azimuth Opportunity Investment Bank Minority 000 0000 000000 0
Bio*One Capital Corporate Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 13 investors. Get the full list »

Alexza Pharmaceuticals Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Symphony Allegro 26-Aug-2009 0000000000 000.00 Drug Discovery
To view Alexza Pharmaceuticals’s complete acquisitions history, request access »

Ready to get started?

Request a free trial